唐氏综合征面积骨密度与体积骨密度结果不一致
该研究纳入75例唐氏综合征患者和76名年龄性别匹配的对照,采用双能X线吸收法测定面积骨密度并计算体积骨密度,同时评估骨小梁评分和跟骨超声。结果显示唐氏综合征患者面积骨密度较低,但体积骨密度和骨微结构正常,提示面积骨密度降低可能与体型较小有关。
要点
- 唐氏综合征患者面积骨密度低于对照,但体积骨密度与对照相似。
- 唐氏综合征患者骨微结构(骨小梁评分和跟骨超声)正常。
- 面积骨密度降低似乎与体型和骨骼尺寸较小有关。
核心结论
- 唐氏综合征患者面积骨密度降低,但似乎与较小的身体和骨骼尺寸有关。
- 估算的体积骨密度在唐氏综合征患者与对照个体中相似。
- 唐氏综合征患者骨微结构正常。
研究设计与样本
- 招募75例唐氏综合征患者和76名无智力障碍的对照,对照按年龄和性别匹配。
- 采用双能X线吸收法测定骨密度并计算体积骨密度,同时测定体成分、骨小梁评分和跟骨超声。
- 检测血清25-羟维生素D、甲状旁腺激素、I型胶原氨基端前肽和I型胶原羧基端交联肽,并采用国际体力活动问卷简表评估体力活动。
- 连续记录三天食物以评估营养摄入。
主要发现
- 唐氏综合征患者身高较对照低(151 ± 11 cm vs 169 ± 9 cm)。
- 腰椎面积骨密度在唐氏综合征患者为0.903 ± 0.124 g/cm2,在对照为0.997 ± 0.115 g/cm2;股骨颈面积骨密度分别为0.761 ± 0.126 g/cm2和0.838 ± 0.115 g/cm2。
- 腰椎体积骨密度在唐氏综合征患者为0.244 ± 0.124 g/cm3,在对照为0.255 ± 0.033 g/cm3;股骨颈体积骨密度分别为0.325 ± 0.073 g/cm3和0.309 ± 0.043 g/cm3。
- 跟骨超声测定的骨微结构在唐氏综合征患者稍好,骨小梁评分两组相似。
- 25-羟维生素D、甲状旁腺激素和I型胶原羧基端交联肽两组相似,I型胶原氨基端前肽在唐氏综合征组较高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Population with Down syndrome (DS) has lower areal BMD, in association with their smaller skeletal size. However, volumetric BMD and other indices of bone microarchitecture, such as trabecular bone score (TBS) and calcaneal ultrasound (QUS), were normal. INTRODUCTION: Patients with DS have a number of risk factors that could predispose them to osteoporosis. Several studies reported that people with DS also have lower areal bone mineral density, but differences in the skeletal size could bias the analysis. METHODS: Seventy-five patients with DS and 76 controls without intellectual disability were recruited. Controls were matched for age and sex. Bone mineral density (BMD) was measure by Dual-energy X-ray Absorptiometry (DXA), and volumetric bone mineral density (vBMD) was calculated by published formulas. Body composition was also measured by DXA. Microarchitecture was measured by TBS and QUS. Serum 25-hidroxyvitamin D (25OHD), parathyroid hormone (PTH), aminoterminal propeptide of type collagen (P1NP), and C-terminal telopeptide of type I collagen (CTX) were also determined. Physical activity was assessed by the International Physical Activity Questionnaires (IPAQ-short form). To evaluate nutritional intake, we recorded three consecutive days of food. RESULTS: DS individuals had lower height (151 ± 11 vs. 169 ± 9 cm). BMD was higher in the controls (lumbar spine (LS) 0.903 ± 0.124 g/cm2 in patients and 0.997 ± 0.115 g/cm2 in the controls; femoral neck (FN) 0.761 ± .126 g/cm2 and 0.838 ± 0.115 g/cm2, respectively). vBMD was similar in the DS group (LS 0.244 ± 0.124 g/cm3; FN 0.325 ± .0.073 g/cm3) and the controls (LS 0.255 ± 0.033 g/cm3; FN 0.309 ± 0.043 g/cm3). Microarchitecture measured by QUS was slightly better in DS, and TBS measures were similar in both groups. 25OHD, PTH, and CTX were similar in both groups. P1NP was higher in the DS group. Time spent on exercise was similar in both groups, but intensity was higher in the control group. Population with DS has correct nutrition. CONCLUSIONS: Areal BMD is reduced in DS, but it seems to be related to the smaller body and skeletal size. In fact, the estimated volumetric BMD is similar in patients with DS and in control individuals. Furthermore, people with DS have normal bone microarchitecture.
引用
- García-Hoyos M, García-Unzueta MT, de Luis D, et al. Diverging results of areal and volumetric bone mineral density in Down syndrome. Osteoporos Int. 2016. PMID: 27838733. doi:10.1007/s00198-016-3814-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。